2002
DOI: 10.1006/clim.2002.5254
|View full text |Cite
|
Sign up to set email alerts
|

Bromelain Treatment Alters Leukocyte Expression of Cell Surface Molecules Involved in Cellular Adhesion and Activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
95
0
8

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
2
1

Relationship

3
4

Authors

Journals

citations
Cited by 98 publications
(106 citation statements)
references
References 33 publications
3
95
0
8
Order By: Relevance
“…the CD14 receptor for bacterial LPS on monocytes and the CD21 activation regulator on B cells; 16). Bromelain also removes cell surface receptors that can serve as receptors for intestinal bacteria (16,(37)(38)(39)(40)(41), which may decrease exposure of immune cells to bacterial antigens that stimulate detrimental immune responses in IBD. Proteolysis by bromelain may also affect production of pro-inflammatory cytokines and chemokines by altering concentrations of regulatory cytokines such as IL-10 or TGF-β that was not analyzed in the current study.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…the CD14 receptor for bacterial LPS on monocytes and the CD21 activation regulator on B cells; 16). Bromelain also removes cell surface receptors that can serve as receptors for intestinal bacteria (16,(37)(38)(39)(40)(41), which may decrease exposure of immune cells to bacterial antigens that stimulate detrimental immune responses in IBD. Proteolysis by bromelain may also affect production of pro-inflammatory cytokines and chemokines by altering concentrations of regulatory cytokines such as IL-10 or TGF-β that was not analyzed in the current study.…”
Section: Discussionmentioning
confidence: 99%
“…One biopsy of each set was treated with 1 mg/ml bromelain (catalog #B-4882; Sigma-Aldrich Chemical Co., St. Louis, MO) in RPMI + 1X pen/strep (media) for 1 hour at 37°C while the other was treated with media alone. These treatment conditions have previously been shown to be sufficient to remove bromelain-sensitive molecules from a variety of different cell types (15,16,21). All biopsies were treated using aliquots derived from the same lot of bromelain.…”
Section: Culture Of Colon Biopsies and Cytokine Assaysmentioning
confidence: 99%
See 1 more Smart Citation
“…Bromelain treatment has previously been shown to remove the CD128a/CXCR1 and CD128b/ CXCR2 receptors for IL-8, a chemokine that stimulates neutrophil chemotaxis and activation, from human neutrophils (22). Therefore, we determined the effect of bromelain treatment on IL-8-stimulated migration of human neutrophils using an in vitro chemotaxis assay.…”
Section: Bromelain Treatment Decreases Rhil-8-induced Migration Of Humentioning
confidence: 99%
“…However, proteolytic activity is required for the anti-inflammatory effect of bromelain on T cell activation and cytokine secretion in vitro (19)(20)(21) and in murine models of inflammatory bowel disease in vivo (17). We previously showed that in vitro bromelain treatment proteolytically removed at least 14 cell surface molecules that have been associated with leukocyte adhesion and/or activation (19,22). Among the bromelain-sensitive molecules identified were CD62L (L-selectin), CD128a (CXCR1) and CD128b (CXCR2).…”
Section: Introductionmentioning
confidence: 99%